Skip to main content
Granules India Ltd. logo

Granules India Ltd. — Investor Relations & Filings

Ticker · GRANULES ISIN · INE101D01020 LEI · 335800HJF1KE335ASX37 BSE.NS Manufacturing
Open in API
Filings indexed 954 across all filing types
Latest filing 2025-07-14 Regulatory Filings
Country IN India
Listing BSE.NS GRANULES

About Granules India Ltd.

https://granulesindia.com/

Granules India Ltd. is a vertically integrated manufacturer specializing in Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). The organization maintains a significant global presence through the large-scale production of essential molecules, including Paracetamol, Ibuprofen, Metformin, Methocarbamol, and Guaifenesin. Its business model emphasizes a complete value chain approach, from core chemical synthesis to final product packaging, ensuring operational efficiency and supply chain security. The company serves a diverse international clientele across more than 75 countries, utilizing advanced manufacturing facilities that comply with global regulatory standards. Key strengths include high-volume production capabilities, cost leadership, and a focus on delivering consistent quality in high-demand therapeutic areas.

Recent filings

Filing Released Lang Actions
Board Meeting — Board Meeting Intimation
Regulatory Filings
2025-07-14 English
Board Meeting — Financial Results
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 99 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. This matches the criteria for a Regulatory Filing (RNS) as a fallback category for minimal or non-informative filings.
2025-07-14 English
Giving guarantees/indemnity/ becoming a surety for third party
Regulatory Filings
2025-07-09 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a short notification addressed to stock exchanges regarding the completion of a US FDA Pre-Approval Inspection (PAI) at a subsidiary's facility. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The document is informational, brief (1708 characters), and does not contain financial data, audit results, or detailed reports. It is not an annual or interim report, earnings release, or any detailed filing. It is a regulatory announcement informing the exchange and public about a compliance event. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-06-28 English
Trading Window
Regulatory Filings Classification · 100% confidence The document text is extremely short (only 92 characters) and contains only a digital signature with no substantive content or financial data. There is no indication of any report, announcement, or detailed information. Given the lack of content, this document does not fit any specific report category and is best classified as a Regulatory Filing (RNS), which serves as a fallback for miscellaneous filings without substantive content.
2025-06-26 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a notification to stock exchanges about the completion of a US FDA inspection at the company's manufacturing facility, including mention of a 483 observation and the company's plan to respond. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure obligations. The document is brief (1519 characters) and serves as an informational announcement rather than a detailed report or financial filing. It does not contain financial data, management discussion, or detailed regulatory filings. It is not an earnings release, annual report, or audit report. It is a regulatory announcement informing the market about a compliance event. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2025-06-20 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.